Oxytocinergic manipulations in corticolimbic circuit differentially affect fear acquisition and extinction

Psychoneuroendocrinology

Volumn 38, Issue 10, 2013, Pages 2184-2195

  Lahoud, Nisrine ^a   Maroun, Mouna ^a  

^a UNIVERSITY OF HAIFA   (Israel)

Author keywords

Amygdala; Anxiety; Extinction; Fear; Oxytocin; Prefrontal; Regulation

Indexed keywords

OXYTOCIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BASOLATERAL AMYGDALA; BEHAVIOR CHANGE; BRAIN FUNCTION; BRAIN REGION; CENTRAL NUCLEUS (AMYGDALA); CONTROLLED STUDY; FEAR; HISTOPATHOLOGY; HORMONAL REGULATION; HORMONE DETERMINATION; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; RECALL; REINFORCEMENT;

AMYGDALA; ANXIETY; EXTINCTION; FEAR; OXYTOCIN; PREFRONTAL; REGULATION;

ANIMALS; BENZODIAZEPINES; CONDITIONING (PSYCHOLOGY); EXTINCTION, PSYCHOLOGICAL; FEAR; LIMBIC SYSTEM; MALE; MENTAL RECALL; NERVE NET; OXYTOCIN; PREFRONTAL CORTEX; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84883860786     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2013.04.006     Document Type: Article

References (67)

1. Akirav I., Raizel H., Maroun M. GABAA agonist to the infralimbic prefrontal cortex or the basolateral amygdala facilitates extinction of conditioned fear. Eur J Neurosci 2006, 23:758-764.
2. Akirav I., Segev A., Motanis H., Maroun M. d-Cycloserine into the BLA reverses the impairing effects of exposure to stress on the extinction of contextual fear, but not conditioned taste aversion. Learn. Mem. 2009, 16:682-686.
3. Akirav I., Maroun M. The role of the medial prefrontal cortex-amygdala circuit in stress effects on the extinction of fear. Neural Plast. 2007, 2007:30873.
4. Barad M., Gean P.W., Lutz B. The role of the amygdala in the extinction of conditioned fear. Biol. Psychiatry 2006, 60(4):322-328.
5. Bartz J.A., Zaki J., Bolger N., Ochsner K.N. Social effects of oxytocin in humans: context and person matter. Trends Cogn. Sci. 2011, 15:301-309.
6. Baskerville T.A., Douglas A.J. Interactions between dopamine and oxytocin in the control of sexual behaviour. Prog. Brain Res. 2008, 170:277-290.
7. Blanchard D.C., Blanchard R.J. Innate and conditioned reactions to threat in rats with amygdaloid lesions. J. Comp. Physiol. Psychol. 1972, 81:281-290.
8. Bohus B., Kovacs G.L., de Wied D. Oxytocin, vasopressin and memory: opposite effects on consolidation and retrieval processes. Brain Res. 1978, 157:414-417.
9. Bosch O.J., Meddle S.L., Beiderbeck D.I., Douglas A.J., Neumann I.D. Brain oxytocin correlates with maternal aggression: link to anxiety. J. Neurosci. 2005, 25:6807-6815.
10. Burgos-Robles A., Vidal-Gonzalez I., Santini E., Quirk G.J. Consolidation of fear extinction requires NMDA receptor-dependent bursting in the ventromedial prefrontal cortex. Neuron 2007, 53:871-880.
11. Campbell A. Attachment, aggression and affiliation: the role of oxytocin in female social behavior. Biol. Psychol. 2008, 77:1-10.
12. Carson D.S., Cornish J.L., Guastella A.J., Hunt G.E., McGregor I.S. Oxytocin decreases methamphetamine self-administration, methamphetamine hyperactivity, and relapse to methamphetamine-seeking behaviour in rats. Neuropharmacology 2010, 58:38-43.
13. Cassell M.D., Freedman L.J., Shi C. The intrinsic organization of the central extended amygdala. Ann. N. Y. Acad. Sci. 1999, 877:217-241.
14. Ciocchi S., Herry C., Grenier F., Wolff S.B., Letzkus J.J., Vlachos I., Ehrlich I., Sprengel R., Deisseroth K., Stadler M.B., Muller C., Luthi A. Encoding of conditioned fear in central amygdala inhibitory circuits. Nature 2010, 468:277-282.
15. Davis M., Shi C. The extended amygdala: are the central nucleus of the amygdala and the bed nucleus of the stria terminalis differentially involved in fear versus anxiety?. Ann. N. Y. Acad. Sci. 1999, 877:281-291.
16. de Wied D., Elands J., Kovacs G. Interactive effects of neurohypophyseal neuropeptides with receptor antagonists on passive avoidance behavior: mediation by a cerebral neurohypophyseal hormone receptor?. Proc. Natl. Acad. Sci. U. S. A. 1991, 88:1494-1498.
17. Debiec J. Peptides of love and fear: vasopressin and oxytocin modulate the integration of information in the amygdala. Bioessays 2005, 27:869-873.
18. Dumont G., Sweep F., Van Der Steen R., Hermsen R., Donders A., Touw D., Van Gerven J., Buitelaar J., Verkes R. Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration. Soc. Neurosci. 2009, 4:359-366.
19. Ferguson J.N., Aldag J.M., Insel T.R., Young L.J. Oxytocin in the medial amygdala is essential for social recognition in the mouse. J. Neurosci. 2001, 21:8278-8285.
20. Fischer-Shofty M., Shamay-Tsoory S.G., Harari H., Levkovitz Y. The effect of intranasal administration of oxytocin on fear recognition. Neuropsychologia 2010, 48:179-184.
21. Gabbott P.L., Warner T.A., Jays P.R., Salway P., Busby S.J. Prefrontal cortex in the rat: projections to subcortical autonomic, motor, and limbic centers. J. Comp. Neurol. 2005, 492:145-177.
22. Gimpl G., Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol. Rev. 2001, 81:629-683.
23. Gould B.R., Zingg H.H. Mapping oxytocin receptor gene expression in the mouse brain and mammary gland using an oxytocin receptor-LacZ reporter mouse. Neuroscience 2003, 122:155-167.
24. Gurden H., Takita M., Jay T.M. Essential role of D1 but not D2 receptors in the NMDA receptor-dependent long-term potentiation at hippocampal-prefrontal cortex synapses in vivo. J. Neurosci. 2000, 20:RC106.
25. Haubensak W., Kunwar P.S., Cai H., Ciocchi S., Wall N.R., Ponnusamy R., Biag J., Dong H.W., Deisseroth K., Callaway E.M., Fanselow M.S., Luthi A., Anderson D.J. Genetic dissection of an amygdala microcircuit that gates conditioned fear. Nature 2010, 468:270-276.
26. Herry C., Garcia R. Prefrontal cortex long-term potentiation, but not long-term depression, is associated with the maintenance of extinction of learned fear in mice. J. Neurosci. 2002, 22:577-583.
27. Hicks C., Jorgensen W., Brown C., Fardell J., Koehbach J., Gruber C.W., Kassiou M., Hunt G.E., McGregor I.S. The nonpeptide oxytocin receptor agonist WAY 267,464: receptor-binding profile, prosocial effects and distribution of c-Fos expression in adolescent rats. J. Neuroendocrinol. 2012, 24:1012-1029.
28. Hikind N., Maroun M. Microinfusion of the D1 receptor antagonist, SCH23390 into the IL but not the BLA impairs consolidation of extinction of auditory fear conditioning. Neurobiol. Learn. Mem. 2008, 90:217-222.
29. Huber D., Veinante P., Stoop R. Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science 2005, 308:245-248.
30. Insel T.R., Shapiro L.E. Oxytocin receptor distribution reflects social organization in monogamous and polygamous voles. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:5981-5985.
31. Insel T.R., Fernald R.D. How the brain processes social information: searching for the social brain. Annu. Rev. Neurosci. 2004, 27:697-722.
32. Kim J.J., Fanselow M.S., DeCola J.P., Landeira-Fernandez J. Selective impairment of long-term but not short-term conditional fear by the N-methyl-d-aspartate antagonist APV. Behav. Neurosci. 1992, 106:591-596.
33. Kim M., Davis M. Electrolytic lesions of the amygdala block acquisition and expression of fear-potentiated startle even with extensive training but do not prevent reacquisition. Behav. Neurosci. 1993, 107(4):580-595.
34. King M.G., Brown R., Kusnecov A. An increase in startle response in rats administered oxytocin. Peptides 1985, 6:567-568.
35. Kirsch P., Esslinger C., Chen Q., Mier D., Lis S., Siddhanti S., Gruppe H., Mattay V.S., Gallhofer B., Meyer-Lindenberg A. Oxytocin modulates neural circuitry for social cognition and fear in humans. J. Neurosci. 2005, 25:11489-11493.
36. Knobloch H.S., Charlet A., Hoffmann L.C., Eliava M., Khrulev S., Cetin A.H., Osten P., Schwarz M.K., Seeburg P.H., Stoop R., Grinevich V. Evoked axonal oxytocin release in the central amygdala attenuates fear response. Neuron 2012, 73:553-566.
37. Kovacs G.L., Bohus B., Versteeg D.H., de Kloet E.R., de Wied D. Effect of oxytocin and vasopressin on memory consolidation: sites of action and catecholaminergic correlates after local microinjection into limbic-midbrain structures. Brain Res. 1979, 175:303-314.
38. Kritman M., Maroun M. Inhibition of the PI3 kinase cascade in corticolimbic circuit: temporal and differential effects on contextual fear and extinction. Int. J. Neuropsychopharmacol. 2012, 16:825-833.
39. Laurent V., Westbrook R.F. Distinct contributions of the basolateral amygdala and the medial prefrontal cortex to learning and relearning extinction of context conditioned fear. Learn. Mem. 2008, 15:657-666.
40. Liu W., Pappas G.D., Carter C.S. Oxytocin receptors in brain cortical regions are reduced in haploinsufficient (+/-) reeler mice. Neurol. Res. 2005, 27:339-345.
41. Maroun M., Kavushansky A., Holmes A., Wellman C., Motanis H. Enhanced extinction of aversive memories by high-frequency stimulation of the rat infralimbic cortex. PLoS ONE 2012, 7:e35853.
42. McCarthy M.M., McDonald C.H., Brooks P.J., Goldman D. An anxiolytic action of oxytocin is enhanced by estrogen in the mouse. Physiol. Behav. 1996, 60:1209-1215.
43. McDonald A.J. Neurons of the lateral and basolateral amygdaloid nuclei: a Golgi study in the rat. J. Comp. Neurol. 1982, 212:293-312.
44. Missig G., Ayers L.W., Schulkin J., Rosen J.B. Oxytocin reduces background anxiety in a fear-potentiated startle paradigm. Neuropsychopharmacology 2010, 35:2607-2616.
45. Motanis H., Maroun M. Exposure to a novel context following contextual fear conditioning enhances the induction of hippocampal long-term potentiation. Eur. J. Neurosci. 2010, 32:840-846.
46. Neumann I.D. Stimuli and consequences of dendritic release of oxytocin within the brain. Biochem. Soc. Trans. 2007, 35:1252-1257.
47. Ninan I. Oxytocin suppresses basal glutamatergic transmission but facilitates activity-dependent synaptic potentiation in the medial prefrontal cortex. J. Neurochem. 2011, 119:324-331.
48. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1998, Academic Press, New York. 4th ed.
49. Ring R.H., Schechter L.E., Leonard S.K., Dwyer J.M., Platt B.J., Graf R., Grauer S., Pulicicchio C., Resnick L., Rahman Z., Sukoff Rizzo S.J., Luo B., Beyer C.E., Logue S.F., Marquis K.L., Hughes Z.A., Rosenzweig-Lipson S. Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist. Neuropharmacology 2010, 58:69-77.
50. Roozendaal B., Wiersma A., Driscoll P., Koolhaas J.M., Bohus B. Vasopressinergic modulation of stress responses in the central amygdala of the Roman high-avoidance and low-avoidance rat. Brain Res. 1992, 596:35-40.
51. Santini E., Quirk G.J., Porter J.T. Fear conditioning and extinction differentially modify the intrinsic excitability of infralimbic neurons. J. Neurosci. 2008, 28:4028-4036.
52. Shamay-Tsoory S.G., Fischer M., Dvash J., Harari H., Perach-Bloom N., Levkovitz Y. Intranasal administration of oxytocin increases envy and schadenfreude (gloating). Biol. Psychiatry 2009, 66:864-870.
53. Slattery D.A., Neumann I.D. Chronic icv oxytocin attenuates the pathological high anxiety state of selectively bred Wistar rats. Neuropharmacology 2010, 58:56-61.
54. Smeltzer M.D., Curtis J.T., Aragona B.J., Wang Z. Dopamine, oxytocin, and vasopressin receptor binding in the medial prefrontal cortex of monogamous and promiscuous voles. Neurosci. Lett. 2006, 394:146-151.
55. Stoehr J.D., Cramer C.P., North W.G. Oxytocin and vasopressin hexapeptide fragments have opposing influences on conditioned freezing behavior. Psychoneuroendocrinology 1992, 17:267-271.
56. Toth I., Neumann I.D., Slattery D.A. Central administration of oxytocin receptor ligands affects cued fear extinction in rats and mice in a timepoint-dependent manner. Psychopharmacology (Berl.) 2012, 223:149-158.
57. Uvnäs-Moberg K., Alster P., Hillegaart V., Ahlenius S. Oxytocin reduces exploratory motor behaviour and shifts the activity towards the centre of the arena in male rats. Acta Physiol. Scand. 1992, 145:429-430.
58. Uvnäs-Moberg K., Ahlenius S., Hillegaart V., Alster P. High doses of oxytocin cause sedation and low doses cause an anxiolytic-like effect in male rats. Pharmacol. Biochem. Behav. 1994, 49:101-106.
59. Uvnas-Moberg K. Oxytocin linked antistress effects - the relaxation and growth response. Acta Physiol. Scand. Suppl. 1997, 640:38-42.
60. Uvnas-Moberg K. Oxytocin may mediate the benefits of positive social interaction and emotions. Psychoneuroendocrinology 1998, 23:819-835.
61. Veinante P., Freund-Mercier M.J. Distribution of oxytocin- and vasopressin-binding sites in the rat extended amygdala: a histoautoradiographic study. J. Comp. Neurol. 1997, 383:305-325.
62. Vidal-Gonzalez I., Vidal-Gonzalez B., Rauch S.L., Quirk G.J. Microstimulation reveals opposing influences of prelimbic and infralimbic cortex on the expression of conditioned fear. Learn. Mem. 2006, 13(6):728-733.
63. Viviani D., Charlet A., van den Burg E., Robinet C., Hurni N., Abatis M., Magara F., Stoop R. Oxytocin selectively gates fear responses through distinct outputs from the central amygdala. Science 2011, 333:104-107.
64. Vouimba R.M., Maroun M. Learning-induced changes in mPFC-BLA connections after fear conditioning, extinction, and reinstatement of fear. Neuropsychopharmacology 2011, 36:2276-2285.
65. Wang Z., Aragona B.J. Neurochemical regulation of pair bonding in male prairie voles. Physiol. Behav. 2004, 83:319-328.
66. Yamamoto Y., Cushing B.S., Kramer K.M., Epperson P.D., Hoffman G.E., Carter C.S. Neonatal manipulations of oxytocin alter expression of oxytocin and vasopressin immunoreactive cells in the paraventricular nucleus of the hypothalamus in a gender-specific manner. Neuroscience 2004, 125:947-955.
67. Zimmerman J.M., Rabinak C.A., McLachlan I.G., Maren S. The central nucleus of the amygdala is essential for acquiring and expressing conditional fear after overtraining. Learn. Mem. 2007, 14:634-644.